Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 5 March 2009, Vol. 113, No. 10, pp. 2229-2237.
Prepublished online as a Blood First Edition Paper on November 14, 2008; DOI 10.1182/blood-2008-04-153304.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2008-04-153304v1
113/10/2229    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jirmanova, L.
Right arrow Articles by Ashwell, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jirmanova, L.
Right arrow Articles by Ashwell, J. D.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

Genetic disruption of p38{alpha} Tyr323 phosphorylation prevents T-cell receptor–mediated p38{alpha} activation and impairs interferon-{gamma} production

Ludmila Jirmanova1, Dandapantula N. Sarma1, Dragana Jankovic2, Paul R. Mittelstadt1, and Jonathan D. Ashwell1

1 Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD; and 2 Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD

T cells possess a p38 activation alternative pathway in which stimulation via the antigen receptor (T-cell receptor [TCR]) induces phosphorylation of p38{alpha} and β on Tyr323. To assess the contribution of this pathway to normal T-cell function, we generated p38{alpha} knockin mice in which Tyr323 was replaced with Phe (p38{alpha}Y323F). TCR-mediated stimulation failed to activate p38{alpha}Y323F as measured by phosphorylation of the Thr-Glu-Tyr activation motif and p38{alpha} catalytic activity. Cell-cycle entry was delayed in TCR-stimulated p38{alpha}Y323F T cells, which also produced less interferon (IFN)–{gamma} than wild-type T cells in response to TCR-mediated but not TCR-independent stimuli. p38{alpha}Y323F mice immunized with T-helper 1 (Th1)–inducing antigens generated normal Th1 effector cells, but these cells produced less IFN-{gamma} than wild-type cells when stimulated through the TCR. Thus, the Tyr323-dependent pathway and not the classic mitogen-activated protein (MAP) kinase cascade is the physiologic means of p38{alpha} activation through the TCR and is necessary for normal Th1 function but not Th1 generation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020